English

Charming Medical Limited

EDGAR

MCTA Report (type unavailable) · filed 2026-09-29

Annual consolidated revenue for 2026: about uref_824479441 4.808M, using the latest reported figures. The previous period, 2025, was about uref_824479441 6.222M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

4.81 million uref_824479441

2026 · uref_824479441

Exact inputs and evidence

Revenue: 4807713 uref_824479441 Source

Operating margin

-0.61%

2026 · %

Exact inputs and evidence

Operating Income: -29237 uref_824479441 Source
Revenue: 4807713 uref_824479441 Source

Operating cash flow

-1.22 million uref_824479441

2026 · uref_824479441

Exact inputs and evidence

Operating Cash Flow: -1215931 uref_824479441 Source

Free cash flow

-1.56 million uref_824479441

2026 · uref_824479441

Exact inputs and evidence

Operating Cash Flow: -1215931 uref_824479441 Source
Capital Expenditure: 339560 uref_824479441 Source

Cash and cash equivalents: 4.7 million uref_824479441 2026-03-31 Source
Exact value

4699273 uref_824479441
Long-term debt including current maturities: 186 thousand uref_824479441 2026-03-31
Exact inputs and evidence

185799 uref_824479441

Long-term debt including current maturities: 185799 uref_824479441 Source
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-09-29.

Financial data available through: 2026-03-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2026-03-31
Operating income: 3 of 11 periods available· newest 2026-03-31
Net income: 3 of 11 periods available· newest 2026-03-31
Operating cash flow: 3 of 11 periods available· newest 2026-03-31
Capital expenditure: 3 of 11 periods available· newest 2026-03-31
Total assets: 2 of 11 periods available· newest 2026-03-31
Total liabilities: 2 of 11 periods available· newest 2026-03-31
Current assets: 2 of 11 periods available· newest 2026-03-31
Current liabilities: 2 of 11 periods available· newest 2026-03-31
Cash and cash equivalents: 2 of 11 periods available· newest 2026-03-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2026-03-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-22.7%

Prior period

uref_824479441 6.22 million

2024-04-01 – 2025-03-31
Current period

uref_824479441 4.81 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

4807713 − 6221751 = -1414038 uref_824479441

6221751 uref_824479441 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
4807713 uref_824479441 · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Year-over-year change in Revenue: -1414038 uref_824479441 Concept: fundies:Revenue Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4807713 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#2096724 Filing: 000121390026083325 Input fundies:Revenue: 6221751 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#2097164 Filing: 000121390026083325
The citation records this snapshot. The page link may show a newer release later.
Net income
-101.9%

Prior period

uref_824479441 1.2 million

2024-04-01 – 2025-03-31
Current period

−uref_824479441 22,648

2025-04-01 – 2026-03-31

Exact inputs and evidence

-22648 − 1199085 = -1221733 uref_824479441

1199085 uref_824479441 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-22648 uref_824479441 · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Year-over-year change in Net income: -1221733 uref_824479441 Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -22648 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1537731 Filing: 000121390026083325 Input fundies:NetIncome: 1199085 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1538237 Filing: 000121390026083325
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-385.5%

Prior period

uref_824479441 425,888

2024-04-01 – 2025-03-31
Current period

−uref_824479441 1.22 million

2025-04-01 – 2026-03-31

Exact inputs and evidence

-1215931 − 425888 = -1641819 uref_824479441

425888 uref_824479441 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
-1215931 uref_824479441 · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Year-over-year change in Operating cash flow: -1641819 uref_824479441 Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1215931 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1696886 Filing: 000121390026083325 Input fundies:OperatingCashFlow: 425888 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1697370 Filing: 000121390026083325
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+18.1%

Prior period

uref_824479441 287,527

2024-04-01 – 2025-03-31
Current period

uref_824479441 339,560

2025-04-01 – 2026-03-31

Exact inputs and evidence

339560 − 287527 = 52033 uref_824479441

287527 uref_824479441 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source
339560 uref_824479441 · 2025-04-01 – 2026-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Year-over-year change in Capital expenditure: 52033 uref_824479441 Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 339560 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699572 Filing: 000121390026083325 Input fundies:CapitalExpenditure: 287527 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699924 Filing: 000121390026083325
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-04-01 – 2026-03-31

Revenue uref_824479441 4.81 million 100% of revenue
Cost of revenue uref_824479441 35,221 0.7% of revenue
Operating expenses uref_824479441 4.84 million 101% of revenue
Other operating costs Derived −uref_824479441 35,221 −0.7% of revenue
Operating income −uref_824479441 29,237 −0.6% of revenue
Tax, interest and other Derived −uref_824479441 6,589 −0.1% of revenue
Net income −uref_824479441 22,648 −0.5% of revenue

Cash

Operating cash flow −uref_824479441 1.22 million −25% of revenue
Capital expenditure uref_824479441 339,560 7.1% of revenue
Free cash flow Derived −uref_824479441 1.56 million −32% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2024 13%83%
2025 19%78%
2026 Operating loss: operating costs were 101% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2024 2023-04-01 – 2024-03-31	6015375	5006527 Derived	1008848	231037 Derived	777811	84831 Derived	Source 2023-04-01 – 2024-03-31: 6015375 uref_824479441 Inspect Revenue Open source 2023-04-01 – 2024-03-31: 1008848 uref_824479441 Inspect Operating Income Open source 2023-04-01 – 2024-03-31: 777811 uref_824479441 Inspect Net Income Open source 2023-04-01 – 2024-03-31: 295429 uref_824479441 Inspect Operating Cash Flow Open source 2023-04-01 – 2024-03-31: 210598 uref_824479441 Inspect Capital Expenditure Open source
2025 2024-04-01 – 2025-03-31	6221751	4832813 Derived	1388938	189853 Derived	1199085	138361 Derived	Source 2024-04-01 – 2025-03-31: 6221751 uref_824479441 Inspect Revenue Open source 2024-04-01 – 2025-03-31: 1388938 uref_824479441 Inspect Operating Income Open source 2024-04-01 – 2025-03-31: 1199085 uref_824479441 Inspect Net Income Open source 2024-04-01 – 2025-03-31: 425888 uref_824479441 Inspect Operating Cash Flow Open source 2024-04-01 – 2025-03-31: 287527 uref_824479441 Inspect Capital Expenditure Open source
2026 2025-04-01 – 2026-03-31	4807713	4836950 Derived	-29237	-6589 Derived	-22648	-1555491 Derived	Source 2025-04-01 – 2026-03-31: 4807713 uref_824479441 Inspect Revenue Open source 2025-04-01 – 2026-03-31: -29237 uref_824479441 Inspect Operating Income Open source 2025-04-01 – 2026-03-31: -22648 uref_824479441 Inspect Net Income Open source 2025-04-01 – 2026-03-31: -1215931 uref_824479441 Inspect Operating Cash Flow Open source 2025-04-01 – 2026-03-31: 339560 uref_824479441 Inspect Capital Expenditure Open source

Amounts are exact, in uref_824479441.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

uref_824479441 4.8M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(uref_824479441)	Source evidence
20242024-03-31	Revenue	6015375	Revenue: 6015375 Open source
20252025-03-31	Revenue	6221751	Revenue: 6221751 Open source
20262026-03-31	Revenue	4807713	Revenue: 4807713 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-22.7% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20242024-03-31	Year over year	No prior comparable period	Revenue: 6015375 Open source
20252025-03-31	Year over year	3.4%	Revenue: 6221751 Open source Revenue: 6015375 Open source
20262026-03-31	Year over year	-22.7%	Revenue: 4807713 Open source Revenue: 6221751 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -0.6% 2026

Net margin -0.5% 2026

Free cash flow margin -32.4% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20242024-03-31	Operating margin	16.8%	Operating Income: 1008848 Open source Revenue: 6015375 Open source
20252025-03-31	Operating margin	22.3%	Operating Income: 1388938 Open source Revenue: 6221751 Open source
20262026-03-31	Operating margin	-0.6%	Operating Income: -29237 Open source Revenue: 4807713 Open source
20242024-03-31	Net margin	12.9%	Net Income: 777811 Open source Revenue: 6015375 Open source
20252025-03-31	Net margin	19.3%	Net Income: 1199085 Open source Revenue: 6221751 Open source
20262026-03-31	Net margin	-0.5%	Net Income: -22648 Open source Revenue: 4807713 Open source
20242024-03-31	Free cash flow margin	1.4%	Revenue: 6015375 Open source Operating Cash Flow: 295429 Open source Capital Expenditure: 210598 Open source
20252025-03-31	Free cash flow margin	2.2%	Revenue: 6221751 Open source Operating Cash Flow: 425888 Open source Capital Expenditure: 287527 Open source
20262026-03-31	Free cash flow margin	-32.4%	Revenue: 4807713 Open source Operating Cash Flow: -1215931 Open source Capital Expenditure: 339560 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

uref_824479441 -1.2M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(uref_824479441)	Source evidence
20242024-03-31	Operating cash flow	295429	Operating Cash Flow: 295429 Open source
20252025-03-31	Operating cash flow	425888	Operating Cash Flow: 425888 Open source
20262026-03-31	Operating cash flow	-1215931	Operating Cash Flow: -1215931 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

uref_824479441 -1.6M 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(uref_824479441)	Source evidence
20242024-03-31	Free cash flow	84831	Operating Cash Flow: 295429 Open source Capital Expenditure: 210598 Open source
20252025-03-31	Free cash flow	138361	Operating Cash Flow: 425888 Open source Capital Expenditure: 287527 Open source
20262026-03-31	Free cash flow	-1555491	Operating Cash Flow: -1215931 Open source Capital Expenditure: 339560 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

47.5% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2024-03-31	Liabilities / assets	Not reported	No source recorded
20252025-03-31	Liabilities / assets	99.1%	Total Liabilities: 5306498 Open source Total Assets: 5355741 Open source
20262026-03-31	Liabilities / assets	47.5%	Total Liabilities: 4687705 Open source Total Assets: 9868667 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.89× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2024-03-31	Current assets / current liabilities	Not reported	No source recorded
20252025-03-31	Current assets / current liabilities	0.68×	Current Assets: 3367211 Open source Current Liabilities: 4948465 Open source
20262026-03-31	Current assets / current liabilities	1.89×	Current Assets: 8174597 Open source Current Liabilities: 4332148 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2024 2023-04-01 – 2024-03-31	uref_824479441 777,811 Exact value Exact value: 777811 uref_824479441 2023-04-01 – 2024-03-31: 777811 uref_824479441 Inspect Net Income Open source Share or cite Citation for Net Income · Charming Medical Limited · 2024-03-31 Charming Medical Limited (edgar:2035992) Net Income: 777811 uref_824479441 Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ANetIncome&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=uref_824479441&dimensions= Input fundies:NetIncome: 777811 uref_824479441 (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1538742 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 295,429 Exact value Exact value: 295429 uref_824479441 2023-04-01 – 2024-03-31: 295429 uref_824479441 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Charming Medical Limited · 2024-03-31 Charming Medical Limited (edgar:2035992) Operating Cash Flow: 295429 uref_824479441 Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=uref_824479441&dimensions= Input fundies:OperatingCashFlow: 295429 uref_824479441 (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1697848 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 210,598 Exact value Exact value: 210598 uref_824479441 2023-04-01 – 2024-03-31: 210598 uref_824479441 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Charming Medical Limited · 2024-03-31 Charming Medical Limited (edgar:2035992) Capital Expenditure: 210598 uref_824479441 Concept: fundies:CapitalExpenditure Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ACapitalExpenditure&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=uref_824479441&dimensions= Input fundies:CapitalExpenditure: 210598 uref_824479441 (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1700276 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 84,831 Calculation and evidence 295429 − 210598 uref_824479441 Exact free cash flow: 84831 uref_824479441 2023-04-01 – 2024-03-31: 295429 uref_824479441 · Inspect Operating Cash Flow · Source 2023-04-01 – 2024-03-31: 210598 uref_824479441 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Charming Medical Limited · 2024-03-31 Charming Medical Limited (edgar:2035992) Free cash flow: 84831 uref_824479441 Concept: free-cash-flow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 295429 uref_824479441 (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1697848 Filing: 000121390026083325 Input fundies:CapitalExpenditure: 210598 uref_824479441 (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1700276 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.
2025 2024-04-01 – 2025-03-31	uref_824479441 1.2 million Exact value Exact value: 1199085 uref_824479441 2024-04-01 – 2025-03-31: 1199085 uref_824479441 Inspect Net Income Open source Share or cite Citation for Net Income · Charming Medical Limited · 2025-03-31 Charming Medical Limited (edgar:2035992) Net Income: 1199085 uref_824479441 Concept: fundies:NetIncome Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ANetIncome&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=uref_824479441&dimensions= Input fundies:NetIncome: 1199085 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1538237 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 425,888 Exact value Exact value: 425888 uref_824479441 2024-04-01 – 2025-03-31: 425888 uref_824479441 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Charming Medical Limited · 2025-03-31 Charming Medical Limited (edgar:2035992) Operating Cash Flow: 425888 uref_824479441 Concept: fundies:OperatingCashFlow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3AOperatingCashFlow&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=uref_824479441&dimensions= Input fundies:OperatingCashFlow: 425888 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1697370 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 287,527 Exact value Exact value: 287527 uref_824479441 2024-04-01 – 2025-03-31: 287527 uref_824479441 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Charming Medical Limited · 2025-03-31 Charming Medical Limited (edgar:2035992) Capital Expenditure: 287527 uref_824479441 Concept: fundies:CapitalExpenditure Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ACapitalExpenditure&period=2025-03-31&surface=latest&period_type=duration&start=2024-04-01&unit=uref_824479441&dimensions= Input fundies:CapitalExpenditure: 287527 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699924 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 138,361 Calculation and evidence 425888 − 287527 uref_824479441 Exact free cash flow: 138361 uref_824479441 2024-04-01 – 2025-03-31: 425888 uref_824479441 · Inspect Operating Cash Flow · Source 2024-04-01 – 2025-03-31: 287527 uref_824479441 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Charming Medical Limited · 2025-03-31 Charming Medical Limited (edgar:2035992) Free cash flow: 138361 uref_824479441 Concept: free-cash-flow Period: 2024-04-01 to 2025-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 425888 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1697370 Filing: 000121390026083325 Input fundies:CapitalExpenditure: 287527 uref_824479441 (2024-04-01 to 2025-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699924 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.
2026 2025-04-01 – 2026-03-31	−uref_824479441 22,648 Exact value Exact value: -22648 uref_824479441 2025-04-01 – 2026-03-31: -22648 uref_824479441 Inspect Net Income Open source Share or cite Citation for Net Income · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Net Income: -22648 uref_824479441 Concept: fundies:NetIncome Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ANetIncome&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=uref_824479441&dimensions= Input fundies:NetIncome: -22648 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1537731 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	−uref_824479441 1.22 million Exact value Exact value: -1215931 uref_824479441 2025-04-01 – 2026-03-31: -1215931 uref_824479441 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Operating Cash Flow: -1215931 uref_824479441 Concept: fundies:OperatingCashFlow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3AOperatingCashFlow&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=uref_824479441&dimensions= Input fundies:OperatingCashFlow: -1215931 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1696886 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	uref_824479441 339,560 Exact value Exact value: 339560 uref_824479441 2025-04-01 – 2026-03-31: 339560 uref_824479441 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Capital Expenditure: 339560 uref_824479441 Concept: fundies:CapitalExpenditure Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992/explain?concept=fundies%3ACapitalExpenditure&period=2026-03-31&surface=latest&period_type=duration&start=2025-04-01&unit=uref_824479441&dimensions= Input fundies:CapitalExpenditure: 339560 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699572 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.	−uref_824479441 1.56 million Calculation and evidence -1215931 − 339560 uref_824479441 Exact free cash flow: -1555491 uref_824479441 2025-04-01 – 2026-03-31: -1215931 uref_824479441 · Inspect Operating Cash Flow · Source 2025-04-01 – 2026-03-31: 339560 uref_824479441 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Charming Medical Limited · 2026-03-31 Charming Medical Limited (edgar:2035992) Free cash flow: -1555491 uref_824479441 Concept: free-cash-flow Period: 2025-04-01 to 2026-03-31 Values: Latest reported Published: 2026-11-08T07:50:51Z Snapshot: 2fadffdafd7abebb35a1dc4c0be369a1adec3de7bdb91e1f36947c4c7054ea7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/2035992?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1215931 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1696886 Filing: 000121390026083325 Input fundies:CapitalExpenditure: 339560 uref_824479441 (2025-04-01 to 2026-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/2035992/000121390026083325/ea0298998-20f_charming.htm#1699572 Filing: 000121390026083325 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 145 latest values · 145 originally reported values

Dataset published 2026-11-08. Source filing dates and reporting periods are shown separately.

Identifiers: 0002035992, 2035992, MCTA, edgar:2035992

Also known as Charming Medical Limited, Charming Medical Ltd

Charming Medical Limited

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-04-01 – 2026-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation